OPRX News and Press, OptimizeRx Corporation From 11/07/25

2025-11-07 05:56:52 ET More on OptimizeRx OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript OptimizeRx: How It Is Changing Pharma Marketing OptimizeRx Non-GAAP EPS of $0.20 beats by $0.15, revenue of $26.1M beats by $2.41M OptimizeRx Q3 2025 Earn...

2025-11-07 05:56:09 ET OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript

2025-11-06 16:09:42 ET More on OptimizeRx OptimizeRx: How It Is Changing Pharma Marketing OptimizeRx Q3 2025 Earnings Preview Seeking Alpha’s Quant Rating on OptimizeRx Historical earnings data for OptimizeRx Financial information for OptimizeR...

-   Q3 revenue of $26.1 million, increased 22% year-over-year -   Q3 gross profit increased 30% year-over-year to $17.5 million -   Increases full year 2025 guidance to a revenue range between $105 million and $109 million and adjusted EBITDA range between $16 mi...

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thur...

2025-10-10 07:08:14 ET from UBS issued a price target of $23.00 for OPRX on 2025-10-10 10:54:40. The adjusted price target was set to $23.00. At the time of the announcement, OPRX was trading at $18.29. The overall price target consensus is at $15.00 with high price of $...

2025-10-09 05:00:00 ET Riding the AI-Healthcare Boom The S&P 500 performance has been mixed as the government shutdown continues , with Democrats and Republicans deadlocked over extending Affordable Care Act tax credits. The S&P 500 and Nasdaq both snapped week-long winn...

2025-10-07 22:02:58 ET ... Read the full article on Seeking Alpha For further details see: OptimizeRx: How The Stock Is Changing Pharma Marketing

WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management wi...